10.17.14
Ironwood Capital, a Connecticut-based private equity firm with over $500 million of institutional capital under management, has announced it has closed on an investment in Pharmaceutic Litho & Label Company, in conjunction with an investment by Saugatuck Capital Company.
Pharmaceutic Litho & Label Company, based in Simi Valley, CA, USA, was founded in 1964 and is a printer of labels and inserts for the pharmaceutical, biotech, and medical device industries. The company is one of the few pharmaceutical printers with over 25,000 sq. ft. dedicated solely to printing pharmaceutical labels.
“Pharmaceutic maintains a unique market niche within the printing industry and an experienced and committed management team,” says Carolyn Galiette, senior managing director, Ironwood Capital.
“Saugatuck’s vision to grow the company is exciting and we’re pleased to be working with them on this investment,” adds Roger Roche, senior managing director.
Pharmaceutic Litho & Label Company, based in Simi Valley, CA, USA, was founded in 1964 and is a printer of labels and inserts for the pharmaceutical, biotech, and medical device industries. The company is one of the few pharmaceutical printers with over 25,000 sq. ft. dedicated solely to printing pharmaceutical labels.
“Pharmaceutic maintains a unique market niche within the printing industry and an experienced and committed management team,” says Carolyn Galiette, senior managing director, Ironwood Capital.
“Saugatuck’s vision to grow the company is exciting and we’re pleased to be working with them on this investment,” adds Roger Roche, senior managing director.